Skip to main content
. 2020 Nov 25;22:129. doi: 10.1186/s13058-020-01365-9

Fig. 3.

Fig. 3

Associations between estrogen plus progestin therapy (EPT) at baseline and risk of breast cancer by histology type among eligible postmenopausal women with intact uteri (n = 68,284) in the entire National Institutes of Health-AARP Diet and Health Study cohort (1996/1997–2011). BC, breast cancer. ER, estrogen receptor. PR, progesterone receptor